Christopher Fenimore, Regeneron Pharmaceuticals CFO, on the record: "We are pleased with our third quarter…"

We are pleased with our third quarter financial results, which marked our third consecutive quarter of double-digit growth in both revenue and non-GAAP EPS

Christopher Fenimore, Executive Vice President, Finance and Chief Financial Officer of Regeneron, Regeneron PharmaceuticalsRegeneron Reports Third Quarter 2026 Financial and Operating Results · October 30, 2026 · source: sec.gov

In context

"We are pleased with our third quarter financial results, which marked our third consecutive quarter of double-digit growth in both revenue and non-GAAP EPS," said Christopher Fenimore, Executive Vice President, Finance and Chief Financial Officer of Regeneron

Verbatim from the company's earnings release at sec.gov, accessed 2026-10-30.

Said October 30, 2026 in the Regeneron Reports Third Quarter 2026 Financial and Operating Results. Regeneron Pharmaceuticals's CFO record: Regeneron Pharmaceuticals on CFO Tribune. We publish quotes as the company released them and add no view on the company's results or shares.

Speaker: Christopher Fenimore (3 quotes)

Company: Regeneron Pharmaceuticals (3 quotes)

Season: Q4 2026 releases